🇺🇸 FDA
Pipeline program

LUMYKRAS 120 mg film-coated tablets, LUMYKRAS 240 mg film-coated tablets

DCC-3116-01-001

Phase 2 small_molecule active

Quick answer

LUMYKRAS 120 mg film-coated tablets, LUMYKRAS 240 mg film-coated tablets for Non-Small Cell Lung Cancer, Metastatic Solid Tumor, Advanced Solid Tumor is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Non-Small Cell Lung Cancer, Metastatic Solid Tumor, Advanced Solid Tumor
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials